Davos26: Trump says tariff threats helped fix US drug pricing ‘unfairness’
The threat of tariffs was necessary to get major drugmakers and foreign leaders on board with drug pricing reforms in…
21 Jan 2026
Pfizer and Novavax ink $530m vaccine delivery licensing deal
Pfizer has signed a deal worth up to $530m with US-based vaccine technology company Novavax. This agreement will see Pfizer hand over $30m upfront for the non-exclusive rights to Novavax’s…
21 Jan 2026
BMS and Microsoft partner for AI-based lung cancer detection
Bristol Myers Squibb (BMS) has entered an agreement with Microsoft to advance AI-driven early lung cancer detection. The collaboration will deploy radiology AI algorithms cleared by the US Food and…
21 Jan 2026
Novo Nordisk and Aspect Biosystems advance partnership for diabetes therapies
Novo Nordisk and Aspect Biosystems have commenced a new phase in their ongoing partnership focused on curative cellular medicines to treat diabetes. The collaboration, which began in 2023, aims to…
20 Jan 2026
Shionogi expands ViiV Healthcare stake by $2.13bn as Pfizer sells up
As Pfizer sells its stake in ViiV Healthcare, Japan-based Shionogi & Co will increase its hold in the human immunodeficiency virus (HIV) medicines developer in a $2.13bn deal. ViiV Healthcare,…
20 Jan 2026
GSK acquires RAPT Therapeutics for $2.2bn
In a bid to bolster its immunology portfolio, GSK is acquiring food allergy specialist RAPT Therapeutics for up to $2.2bn. This buyout, which is one of the first major deals…
20 Jan 2026
DeepHow introduces PharmaCloud for pharmaceutical manufacturers
DeepHow has launched PharmaCloud, a good manufacturing practice (GMP)-compliant cloud environment developed specifically to standardise AI-driven operator training in pharma manufacturing. The new solution is intended for pharmaceutical and medical…